Breast conservation after neoadjuvant therapy for tumors ≥5 cm: A prospective cohort study
نویسندگان
چکیده
منابع مشابه
Changes in Cytokeratin 18 during Neoadjuvant Chemotherapy of Breast Cancer: A Prospective Study
Background & Objective: Premalignant lesions of cervix have increased dramatically in recent years. Early diagnosis and management of abnormalitie...
متن کاملNomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy
PURPOSE The ability to accurately predict the likelihood of achieving breast conservation surgery (BCS) after neoadjuvant chemotherapy (NCT) is important in deciding whether NCT or surgery should be the first-line treatment in patients with operable breast cancers. MATERIALS AND METHODS We reviewed the data of 513 women, who had stage II or III breast cancer and received NCT and surgery from ...
متن کاملFeasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial
BACKGROUND Neoadjuvant chemotherapy is the standard care for locally advanced breast cancer. Our study aimed at evaluating the feasibility of breast conversation surgery (BCS) after neoadjuvant chemotherapy. PATIENTS AND METHODS Forty five patients had stage IIB (except those with T2N1 disease) and stage IIIA were selected to 3 cycles taxane-based neoadjuvant chemotherapy. Patient who had tum...
متن کاملSentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
BACKGROUND The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy. METHODS SENTINA is a four-arm, prospective, multicent...
متن کامل3D ultrasound in neoadjuvant therapy of breast tumors
The iU22 is provided with the new VL13-5 3D linear array transducer (Figure 1). This transducer combines an easy-to-use ergonomic design with state-of-the-art imaging capabilities, including Tissue Aberration Correction (TAC). TAC is a new technology that corrects for the different speeds of sound associated with different tissue types, such as fat and glandular tissue in the breast, resulting ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Surgery Open
سال: 2015
ISSN: 2405-8572
DOI: 10.1016/j.ijso.2015.12.001